Log in to save to my catalogue

Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8816826

Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

About this item

Full title

Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

Publisher

United States: Wolters Kluwer

Journal title

The American journal of gastroenterology, 2022-02, Vol.117 (2), p.295-300

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer

More information

Scope and Contents

Contents

Bowel movement (BM) frequency is used to titrate lactulose for hepatic encephalopathy (HE). However, stool consistency using the Bristol stool scale (BSS, 0-7) is often ignored.
The study included pre-BSS and post-BSS cohorts. BSS was incorporated into decision-making after training in outpatients with cirrhosis. Two to 3 BMs/d and BSS 3-4 were...

Alternative Titles

Full title

Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8816826

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8816826

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/ajg.0000000000001550

How to access this item